Thanks Narmac for your posts on Veru. I looked at Veru's website to see what they were about and in particular their Covid path for Sabizabulin (Veru-111).  Seems that Veru announced they were going to take a shot at Covid in May/20, Don was yapping about imminently beginning a Covid trial in Feb/20.  Veru's actual start date for a ph2 was June 18/20 and their primary completion was Dec 18/20. Don was still talking. Veru's actual start date for their ph3 was May 18/21. Don was still yapping and somewhere along the way started telling us how tough it was to get a Covid trial run. As per Narmac's post the Veru ph3 was halted early for efficacy.  (Info as per clinicaltrials.gov)

The Veru story seems to indicate that good management teams can indeed get Covid trials run. From the outside it is hard not to read from this that poor management is costing RVX dearly in the Covid arena. Some management teams just do a lot of talking while others get things done. JMO